387 related articles for article (PubMed ID: 21258397)
1. Mouse models of advanced spontaneous metastasis for experimental therapeutics.
Francia G; Cruz-Munoz W; Man S; Xu P; Kerbel RS
Nat Rev Cancer; 2011 Feb; 11(2):135-41. PubMed ID: 21258397
[TBL] [Abstract][Full Text] [Related]
2. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
Man S; Munoz R; Kerbel RS
Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
[TBL] [Abstract][Full Text] [Related]
3. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
Kerbel RS
Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
[TBL] [Abstract][Full Text] [Related]
4. Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic.
Hoffman RM
Invest New Drugs; 1999; 17(4):343-59. PubMed ID: 10759402
[TBL] [Abstract][Full Text] [Related]
5. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived-but they can be improved.
Kerbel RS
Cancer Biol Ther; 2003; 2(4 Suppl 1):S134-9. PubMed ID: 14508091
[TBL] [Abstract][Full Text] [Related]
6. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
7. Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.
Fiebig HH; Maier A; Burger AM
Eur J Cancer; 2004 Apr; 40(6):802-20. PubMed ID: 15120036
[TBL] [Abstract][Full Text] [Related]
8. Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis.
Kerbel RS; Guerin E; Francia G; Xu P; Lee CR; Ebos JM; Man S
Breast; 2013 Aug; 22 Suppl 2():S57-65. PubMed ID: 24074794
[TBL] [Abstract][Full Text] [Related]
9. Contemporary pre-clinical development of anticancer agents--what are the optimal preclinical models?
Damia G; D'Incalci M
Eur J Cancer; 2009 Nov; 45(16):2768-81. PubMed ID: 19762228
[TBL] [Abstract][Full Text] [Related]
10. The relevance of animal tumour models to the preclinical screening of cytokines.
Kelly SA; Malik ST; Balkwill FR
Cancer Surv; 1989; 8(4):741-54. PubMed ID: 2484311
[TBL] [Abstract][Full Text] [Related]
11. Metastasis models for human tumors in athymic mice: useful models for drug development.
Fine DL; Shoemaker R; Gazdar A; Mayo JG; Fodstad O; Boyd MR; Abbott BJ; Donovan PA
Cancer Detect Prev Suppl; 1987; 1():291-9. PubMed ID: 3480056
[TBL] [Abstract][Full Text] [Related]
12. The potential clinical promise of 'multimodality' metronomic chemotherapy revealed by preclinical studies of metastatic disease.
Kerbel RS; Shaked Y
Cancer Lett; 2017 Aug; 400():293-304. PubMed ID: 28202353
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice].
Tuo CW; Zhang N; Liu QZ; Yang B; Wang MY
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):885-90. PubMed ID: 19173986
[TBL] [Abstract][Full Text] [Related]
14. Suppression of rat breast cancer metastasis and reduction of primary tumour growth by the small synthetic urokinase inhibitor WX-UK1.
Setyono-Han B; Stürzebecher J; Schmalix WA; Muehlenweg B; Sieuwerts AM; Timmermans M; Magdolen V; Schmitt M; Klijn JG; Foekens JA
Thromb Haemost; 2005 Apr; 93(4):779-86. PubMed ID: 15841327
[TBL] [Abstract][Full Text] [Related]
15. Anti-MUC-1 immunoliposomal doxorubicin in the treatment of murine models of metastatic breast cancer.
Moase EH; Qi W; Ishida T; Gabos Z; Longenecker BM; Zimmermann GL; Ding L; Krantz M; Allen TM
Biochim Biophys Acta; 2001 Feb; 1510(1-2):43-55. PubMed ID: 11342146
[TBL] [Abstract][Full Text] [Related]
16. Rapid identification of antimicrometastases drugs using integrated model systems with two dimensional monolayer, three dimensional spheroids, and zebrafish xenotransplantation tumors.
Fu A; Peh YM; Ngan W; Wei N; Luo KQ
Biotechnol Bioeng; 2018 Nov; 115(11):2828-2843. PubMed ID: 30102771
[TBL] [Abstract][Full Text] [Related]
17. [Highly metastatic nude mouse model of human primary gastric lymphoma constructed by surgical orthotopic transplantation and in vivo continuous screening method].
Yang B; Tuo S; Tuo CW; Zhang N; Liu QZ
Zhonghua Yi Xue Za Zhi; 2010 Feb; 90(6):413-7. PubMed ID: 20367942
[TBL] [Abstract][Full Text] [Related]
18. Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy.
Giovanella BC; Stehlin JS; Williams LJ; Lee SS; Shepard RC
Cancer; 1978 Nov; 42(5):2269-81. PubMed ID: 719607
[TBL] [Abstract][Full Text] [Related]
19. Human tumor xenografts in athymic nude mice as a preclinical screen for anticancer agents.
Ovejera AA; Houchens DP
Semin Oncol; 1981 Dec; 8(4):386-93. PubMed ID: 7323810
[No Abstract] [Full Text] [Related]
20. Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases.
Yap ML; McFadyen JD; Wang X; Ziegler M; Chen YC; Willcox A; Nowell CJ; Scott AM; Sloan EK; Hogarth PM; Pietersz GA; Peter K
Theranostics; 2019; 9(4):1154-1169. PubMed ID: 30867822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
